{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:44:52Z","timestamp":1787111092548,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1559-0275-10-16","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T12:01:24Z","timestamp":1383912084000},"source":"Crossref","is-referenced-by-count":39,"title":["Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring"],"prefix":"10.1186","volume":"10","author":[{"given":"Ferdinando","family":"Cerciello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nicastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damaris","family":"Bausch-Fluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruedi","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Wollscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"46_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999, 117: 54-63. discussion 63\u201355,","journal-title":"J Thorac Cardiovasc Surg"},{"key":"46_CR2","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","volume":"22","author":"W Weder","year":"2004","unstructured":"Weder W, Kestenholz P, Taverna C, Bodis S, Lardinois D, Jerman M, Stahel RA: Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol. 2004, 22: 3451-3457.","journal-title":"J Clin Oncol"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","volume":"1","author":"RM Flores","year":"2006","unstructured":"Flores RM, Krug LM, Rosenzweig KE, Venkatraman E, Vincent A, Heelan R, Akhurst T, Rusch VW: Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol. 2006, 1: 289-295.","journal-title":"J Thorac Oncol"},{"key":"46_CR4","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","volume":"18","author":"W Weder","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R: Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007, 18: 1196-1202.","journal-title":"Ann Oncol"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M: Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009, 27: 3007-3013.","journal-title":"J Clin Oncol"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3816\/CLC.2009.n.033","volume":"10","author":"BE Wilcox","year":"2009","unstructured":"Wilcox BE, Subramaniam RM, Peller PJ, Aughenbaugh GL, Nichols Iii FC, Aubry MC, Jett JR: Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer. 2009, 10: 244-248.","journal-title":"Clin Lung Cancer"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.ejcts.2008.07.050","volume":"34","author":"JB Sorensen","year":"2008","unstructured":"Sorensen JB, Ravn J, Loft A, Brenoe J, Berthelsen AK: Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2008, 34: 1090-1096.","journal-title":"Eur J Cardiothorac Surg"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","volume":"27","author":"M de Perrot","year":"2009","unstructured":"de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, Roberts H, Tsao MS, Leighl N, Keshavjee S, Johnston MR: Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009, 27: 1413-1418.","journal-title":"J Clin Oncol"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I: Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003, 362: 1612-1616.","journal-title":"Lancet"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","volume":"30","author":"K Hollevoet","year":"2012","unstructured":"Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A, Cristaudo A, Pass HI, Nackaerts K, Rodriguez Portal JA: Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol. 2012, 30: 1541-1549.","journal-title":"J Clin Oncol"},{"key":"46_CR11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","volume":"367","author":"HI Pass","year":"2012","unstructured":"Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L: Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012, 367: 1417-1427.","journal-title":"N Engl J Med"},{"key":"46_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/prca.200900217","volume":"4","author":"Q Fu","year":"2010","unstructured":"Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE: Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl. 2010, 4: 271-284.","journal-title":"Proteomics Clin Appl"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nmeth.2291","volume":"10","author":"P Picotti","year":"2013","unstructured":"Picotti P, Bodenmiller B, Aebersold R: Proteomics meets the scientific method. Nat Methods. 2013, 10: 24-27.","journal-title":"Nat Methods"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/msb.2008.61","volume":"4","author":"V Lange","year":"2008","unstructured":"Lange V, Picotti P, Domon B, Aebersold R: Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008, 4: 222","journal-title":"Mol Syst Biol"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nbt.1546","volume":"27","author":"TA Addona","year":"2009","unstructured":"Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009, 27: 633-641.","journal-title":"Nat Biotechnol"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1021\/pr1011087","volume":"10","author":"S Elschenbroich","year":"2011","unstructured":"Elschenbroich S, Ignatchenko V, Clarke B, Kalloger S, Boutros P, Gramolini A, Shaw P, Jurisica I, Kislinger T: In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J Proteome Res. 2011, 10: 2286-2299.","journal-title":"J Proteome Res"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nbt.1900","volume":"29","author":"JR Whiteaker","year":"2011","unstructured":"Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, Yan P, Schoenherr RM, Zhao L, Voytovich UJ: A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol. 2011, 29: 625-634.","journal-title":"Nat Biotechnol"},{"key":"46_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.lungcan.2011.07.009","volume":"75","author":"A Ziegler","year":"2012","unstructured":"Ziegler A, Cerciello F, Bigosch C, Bausch-Fluck D, Felley-Bosco E, Ossola R, Soltermann A, Stahel RA, Wollscheid B: Proteomic surfaceome analysis of mesothelioma. Lung Cancer. 2012, 75: 189-196.","journal-title":"Lung Cancer"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002, 1: 845-867.","journal-title":"Mol Cell Proteomics"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nbt827","volume":"21","author":"H Zhang","year":"2003","unstructured":"Zhang H, Li XJ, Martin DB, Aebersold R: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003, 21: 660-666.","journal-title":"Nat Biotechnol"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nprot.2007.42","volume":"2","author":"Y Tian","year":"2007","unstructured":"Tian Y, Zhou Y, Elliott S, Aebersold R, Zhang H: Solid-phase extraction of N-linked glycopeptides. Nat Protoc. 2007, 2: 334-339.","journal-title":"Nat Protoc"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1021\/ac0623181","volume":"79","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Aebersold R, Zhang H: Isolation of N-linked glycopeptides from plasma. Anal Chem. 2007, 79: 5826-5837.","journal-title":"Anal Chem"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1074\/mcp.M700132-MCP200","volume":"6","author":"J Stahl-Zeng","year":"2007","unstructured":"Stahl-Zeng J, Lange V, Ossola R, Eckhardt K, Krek W, Aebersold R, Domon B: High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics. 2007, 6: 1809-1817.","journal-title":"Mol Cell Proteomics"},{"key":"46_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nmeth.1408","volume":"7","author":"P Picotti","year":"2010","unstructured":"Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, Wenschuh H, Aebersold R: High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods. 2010, 7: 43-46.","journal-title":"Nat Methods"},{"key":"46_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.93.1.136","volume":"93","author":"K Chang","year":"1996","unstructured":"Chang K, Pastan I: Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A. 1996, 93: 136-140.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","volume":"15","author":"I Hellstrom","year":"2006","unstructured":"Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KE: Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1014-1020.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR27","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1055-9965.EPI-06-0479","volume":"15","author":"M Ho","year":"2006","unstructured":"Ho M, Onda M, Wang QC, Hassan R, Pastan I, Lively MO: Mesothelin is shed from tumor cells. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1751","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","volume":"53","author":"HL Beyer","year":"2007","unstructured":"Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, Miller MC, Verch T, Allard WJ, Pass HI, Sardesai NY: MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem. 2007, 53: 666-672.","journal-title":"Clin Chem"},{"key":"46_CR29","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","volume":"96","author":"N Scholler","year":"1999","unstructured":"Scholler N, Fu N, Yang Y, Ye Z, Goodman GE, Hellstrom KE, Hellstrom I: Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A. 1999, 96: 11531-11536.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nbt.1532","volume":"27","author":"B Wollscheid","year":"2009","unstructured":"Wollscheid B, Bausch-Fluck D, Henderson C, O\u2019Brien R, Bibel M, Schiess R, Aebersold R, Watts JD: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009, 27: 378-386.","journal-title":"Nat Biotechnol"},{"key":"46_CR31","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1021\/pr200156b","volume":"10","author":"E de Graaf","year":"2011","unstructured":"de Graaf E, Altelaar A, van Breukelen B, Mohammed S, Heck A: Improving SRM assay development: a global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra. J Proteome Res. 2011, 10: 4334-4341.","journal-title":"J Proteome Res"},{"key":"46_CR32","doi-asserted-by":"publisher","first-page":"M110 006353","DOI":"10.1074\/mcp.M110.006353","volume":"10","author":"T Farrah","year":"2012","unstructured":"Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmstrom J, Ossola R: A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics. 2012, 10: M110 006353","journal-title":"Mol Cell Proteomics"},{"key":"46_CR33","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMoa051185","volume":"353","author":"HI Pass","year":"2005","unstructured":"Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A: Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med. 2005, 353: 1564-1573.","journal-title":"N Engl J Med"},{"key":"46_CR34","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.clinbiochem.2009.03.007","volume":"42","author":"B Grigoriu","year":"2009","unstructured":"Grigoriu B, Chahine B, Zerimech F, Gregoire M, Balduyck M, Copin MC, Devos P, Lassalle P, Scherpereel A: Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma. Clin Biochem. 2009, 42: 1046-1050.","journal-title":"Clin Biochem"},{"key":"46_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","volume":"181","author":"K Hollevoet","year":"2010","unstructured":"Hollevoet K, Nackaerts K, Thimpont J, Germonpre P, Bosquee L, De Vuyst P, Legrand C, Kellen E, Kishi Y, Delanghe JR, van Meerbeeck JP: Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med. 2010, 181: 620-625.","journal-title":"Am J Respir Crit Care Med"},{"key":"46_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0169-5002(99)00044-6","volume":"25","author":"H Schouwink","year":"1999","unstructured":"Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P: Prognostic value of the serum tumour markers Cyfra 21\u20131 and tissue polypeptide antigen in malignant mesothelioma. Lung Cancer. 1999, 25: 25-32.","journal-title":"Lung Cancer"},{"key":"46_CR37","doi-asserted-by":"publisher","first-page":"M111 014662","DOI":"10.1074\/mcp.M111.014662","volume":"11","author":"CY Chang","year":"2012","unstructured":"Chang CY, Picotti P, H\u00fcttenhain R, Heinzelmann-Schwarz V, Jovanovic M, Aebersold R, Vitek O: Protein significance analysis in selected reaction monitoring (SRM) measurements. Mol Cell Proteomics. 2012, 11: M111 014662","journal-title":"Mol Cell Proteomics"},{"key":"46_CR38","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","volume":"93","author":"MS Pepe","year":"2001","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001, 93: 1054-1061.","journal-title":"J Natl Cancer Inst"},{"key":"46_CR39","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1055-9965.EPI-10-0580","volume":"19","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Chan DW: The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2995-2999.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1039\/C0MB00159G","volume":"7","author":"S Elschenbroich","year":"2011","unstructured":"Elschenbroich S, Kislinger T: Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol Biosyst. 2011, 7: 292-303.","journal-title":"Mol Biosyst"},{"key":"46_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006, 24: 971-983.","journal-title":"Nat Biotechnol"},{"key":"46_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10059-010-0159-z","volume":"30","author":"J Roth","year":"2010","unstructured":"Roth J, Zuber C, Park S, Jang I, Lee Y, Kysela K, Fourn VL, Santimaria R, Guhl B, Cho J: Protein N-glycosylation, protein folding, and protein quality control. Mol Cells. 2010, 30: 497-506.","journal-title":"Mol Cells"},{"key":"46_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1074\/mcp.M600160-MCP200","volume":"6","author":"H Zhang","year":"2007","unstructured":"Zhang H, Liu AY, Loriaux P, Wollscheid B, Zhou Y, Watts JD, Aebersold R: Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics. 2007, 6: 64-71.","journal-title":"Mol Cell Proteomics"},{"key":"46_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nbt.1524","volume":"27","author":"VA Fusaro","year":"2009","unstructured":"Fusaro VA, Mani DR, Mesirov JP, Carr SA: Prediction of high-responding peptides for targeted protein assays by mass spectrometry. Nat Biotechnol. 2009, 27: 190-198.","journal-title":"Nat Biotechnol"},{"key":"46_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt0710-659","volume":"28","author":"MW Duncan","year":"2010","unstructured":"Duncan MW, Aebersold R, Caprioli RM: The pros and cons of peptide-centric proteomics. Nat Biotechnol. 2010, 28: 659-664.","journal-title":"Nat Biotechnol"},{"key":"46_CR46","doi-asserted-by":"publisher","first-page":"e23090","DOI":"10.1371\/journal.pone.0023090","volume":"6","author":"Q Fang","year":"2011","unstructured":"Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash S, Agus DB, McIntosh MW, Mallick P: Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma. PLoS One. 2011, 6: e23090","journal-title":"PLoS One"},{"key":"46_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/fon.12.161","volume":"9","author":"J Wang","year":"2013","unstructured":"Wang J, Willumsen N, Zheng Q, Xue Y, Karsdal MA, Bay-Jensen AC: Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology. Future Oncol. 2013, 9: 35-44.","journal-title":"Future Oncol"},{"key":"46_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/0008-5472.CAN-10-2301","volume":"71","author":"SE Craig","year":"2011","unstructured":"Craig SE, Brady-Kalnay SM: Cancer cells cut homophilic cell adhesion molecules and run. Cancer Res. 2011, 71: 303-309.","journal-title":"Cancer Res"},{"key":"46_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tcb.2010.12.002","volume":"21","author":"SD Mason","year":"2011","unstructured":"Mason SD, Joyce JA: Proteolytic networks in cancer. Trends Cell Biol. 2011, 21: 228-237.","journal-title":"Trends Cell Biol"},{"key":"46_CR50","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1021\/bi400437d","volume":"52","author":"JA Wilken","year":"2013","unstructured":"Wilken JA, Perez-Torres M, Nieves-Alicea R, Cora EM, Christensen TA, Baron AT, Maihle NJ: Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease\/fibronectin\/integrin axis and inhibited by cetuximab. Biochemistry. 2013, 52: 4531-4540.","journal-title":"Biochemistry"},{"key":"46_CR51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1541-7786.315.2.6","volume":"2","author":"JM Ebos","year":"2004","unstructured":"Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS: A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res. 2004, 2: 315-326.","journal-title":"Mol Cancer Res"},{"key":"46_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10428194.2011.616611","volume":"53","author":"N Shah","year":"2012","unstructured":"Shah N, Cabanillas F, McIntyre B, Feng L, McLaughlin P, Rodriguez MA, Romaguera J, Younes A, Hagemeister FB, Kwak L, Fayad L: Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas. Leuk Lymphoma. 2012, 53: 50-56.","journal-title":"Leuk Lymphoma"},{"key":"46_CR53","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","volume":"15","author":"RV Iozzo","year":"2011","unstructured":"Iozzo RV, Sanderson RD: Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011, 15: 1013-1031.","journal-title":"J Cell Mol Med"},{"key":"46_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","volume":"64","author":"A Nanda","year":"2004","unstructured":"Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW, Croix BS: TEM8 Interacts with the cleaved C5 domain of collagen \u03b13(VI). Cancer Res. 2004, 64: 817-820.","journal-title":"Cancer Res"},{"key":"46_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1442-2042.2002.00519.x","volume":"9","author":"T Miyagi","year":"2002","unstructured":"Miyagi T, Hori O, Koshida K, Egawa M, Kato H, Kitagawa Y, Ozawa K, Ogawa S, Namiki M: Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells. Int J Urol. 2002, 9: 577-585.","journal-title":"Int J Urol"},{"key":"46_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrc2561","volume":"9","author":"JS Isenberg","year":"2009","unstructured":"Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD: Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer. 2009, 9: 182-194.","journal-title":"Nat Rev Cancer"},{"key":"46_CR57","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1379\/1466-1268(2000)005<0276:THAGSP>2.0.CO;2","volume":"5","author":"DP Easton","year":"2000","unstructured":"Easton DP, Kaneko Y, Subjeck JR: The Hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones. 2000, 5: 276-290.","journal-title":"Cell Stress Chaperones"},{"key":"46_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jri.2009.09.006","volume":"84","author":"S Naaby-Hansen","year":"2010","unstructured":"Naaby-Hansen S, Herr JC: Heat shock proteins on the human sperm surface. J Reprod Immunol. 2010, 84: 32-40.","journal-title":"J Reprod Immunol"},{"key":"46_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-7827-1-27","volume":"1","author":"ME Calvert","year":"2003","unstructured":"Calvert ME, Digilio LC, Herr JC, Coonrod SA: Oolemmal proteomics \u2013 identification of highly abundant heat shock proteins and molecular chaperones in the mature mouse egg and their localization on the plasma membrane. Reprod Biol Endocrinol. 2003, 1: 27-37.","journal-title":"Reprod Biol Endocrinol"},{"key":"46_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ymeth.2007.06.001","volume":"43","author":"SH Beachy","year":"2007","unstructured":"Beachy SH, Kisailus AJ, Repasky EA, Subjeck JR, Wang XY, Kazim AL: Engineering secretable forms of chaperones for immune modulation and vaccine development. Methods. 2007, 43: 184-193.","journal-title":"Methods"},{"key":"46_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9","volume":"69","author":"A Altmeyer","year":"1996","unstructured":"Altmeyer A, Maki R, Feldweg A, Heike M, Protopopov V, Masur S, Srivastava P: Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer. 1996, 69: 340-349.","journal-title":"Int J Cancer"},{"key":"46_CR62","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4049\/jimmunol.172.2.972","volume":"172","author":"R Gastpar","year":"2004","unstructured":"Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, Multhoff G: The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol. 2004, 172: 972-980.","journal-title":"J Immunol"},{"key":"46_CR63","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.4049\/jimmunol.180.6.4299","volume":"180","author":"VL Vega","year":"2008","unstructured":"Vega VL, Rodr\u0131\u2019guez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, Multhoff G, Arispe N, Maio AD: Hsp70 Translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol. 2008, 180: 4299-4307.","journal-title":"J Immunol"},{"key":"46_CR64","doi-asserted-by":"publisher","first-page":"142ra194","DOI":"10.1126\/scitranslmed.3003989","volume":"4","author":"R H\u00fcttenhain","year":"2012","unstructured":"H\u00fcttenhain R, Soste M, Selevsek N, R\u00f6st H, Sethi A, Carapito C, Farrah T, Deutsch EW, Kusebauch U, Moritz RL: Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med. 2012, 4: 142ra194","journal-title":"Sci Transl Med"},{"key":"46_CR65","unstructured":"The SRMAtlas. http:\/\/www.srmatlas.org ,"},{"key":"46_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","volume":"64","author":"C Thurneysen","year":"2009","unstructured":"Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E: Functional inactivation of NF2\/merlin in human mesothelioma. Lung Cancer. 2009, 64: 140-147.","journal-title":"Lung Cancer"},{"key":"46_CR67","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1593\/neo.11828","volume":"13","author":"PA Knobel","year":"2011","unstructured":"Knobel PA, Kotov IN, Felley-Bosco E, Stahel RA, Marti TM: Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells. Neoplasia. 2011, 13: 961-970.","journal-title":"Neoplasia"},{"key":"46_CR68","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/nbt1031","volume":"22","author":"PG Pedrioli","year":"2004","unstructured":"Pedrioli PG, Eng JK, Hubley R, Vogelzang M, Deutsch EW, Raught B, Pratt B, Nilsson E, Angeletti RH, Apweiler R: A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol. 2004, 22: 1459-1466.","journal-title":"Nat Biotechnol"},{"key":"46_CR69","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1002\/pmic.200700057","volume":"7","author":"LN Mueller","year":"2007","unstructured":"Mueller LN, Rinner O, Schmidt A, Letarte S, Bodenmiller B, Brusniak MY, Vitek O, Aebersold R, M\u00fcller M: SuperHirn - a novel tool for high resolution LC-MS-based peptide\/protein profiling. Proteomics. 2007, 7: 3470-3480.","journal-title":"Proteomics"},{"key":"46_CR70","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","volume":"5","author":"JK Eng","year":"1994","unstructured":"Eng JK, McCormack AL, Yates JR: An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994, 5: 976-989.","journal-title":"J Am Soc Mass Spectrom"},{"key":"46_CR71","unstructured":"The UniProt Knowledgebase. (UniProtKB) http:\/\/www.uniprot.org ,"},{"key":"46_CR72","unstructured":"Blood Transfusion Service Z\u00fcrich, SRC, Switzerland. http:\/\/www.zhbsd.ch ,"},{"key":"46_CR73","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ: Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010, 26: 966-968.","journal-title":"Bioinformatics"},{"key":"46_CR74","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pmic.201100463","volume":"12","author":"C Escher","year":"2012","unstructured":"Escher C, Reiter L, Maclean B, Ossola R, Herzog F, Chilton J, Maccoss MJ, Rinner O: Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics. 2012, 12: 1111-1121.","journal-title":"Proteomics"},{"key":"46_CR75","unstructured":"Laboratory for Statistical Proteomics and Bioinformatics. http:\/\/www.stat.purdue.edu\/~ovitek\/Home.html ,"},{"key":"46_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M: pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinforma. 2011, 12: 77","journal-title":"BMC Bioinforma"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1559-0275-10-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1559-0275-10-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1559-0275-10-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:02:07Z","timestamp":1688634127000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/1559-0275-10-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,8]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/1559-0275-10-16","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,8]]},"article-number":"16"}}